The conversation around fraud in laboratory billing, especially in genetic and molecular diagnostics, is no longer theoretical.

In 2026, health plans, Medicare Advantage organizations, and risk adjustment coding companies across the US face growing...
read more
In today’s US healthcare market, laboratory revenue cycle management (lab RCM) is no longer just about clean billing – i...
read more
Revenue cycle management in medical billing has always been driven by expertise, disciplined workflows, and compliance-f...
read more
For U.S. healthcare providers, 2026 represents a genuine inflection point for accounts receivable (AR) – driven by sever...
read more
Medicare clawbacks related to urinary tract infection (UTI) testing are no longer isolated compliance events. As we move...
read more
As Home Health Agencies (HHAs) move into 2026, the finalized CMS CY 2026 Home Health Prospective Payment System (HH PPS)...
read more
In U.S. healthcare, small process gaps can have big financial consequences. The revenue cycle – from patient registratio...
read more
The upcoming ICD-10 codes for 2026 promise pertinent changes for revenue cycle departments. To help your leadership prep...
read more
Anesthesia billing is increasing in complexity, and healthcare revenue cycle leaders should be ready to make adjustments...
read more